Cargando…

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure

Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a predictor of liver events in hepatitis C virus (HCV)-infected patients. The study aim was to identify genetic factors associated with LS changes from the moment of starting anti-HCV t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corma-Gómez, Anaïs, Macías, Juan, Rivero, Antonio, Rivero-Juarez, Antonio, de los Santos, Ignacio, Reus-Bañuls, Sergio, Morano, Luis, Merino, Dolores, Palacios, Rosario, Galera, Carlos, Fernández-Fuertes, Marta, González-Serna, Alejandro, de Rojas, Itziar, Ruiz, Agustín, Sáez, María E., Real, Luis M., Pineda, Juan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394459/ https://www.ncbi.nlm.nih.gov/pubmed/34441435 http://dx.doi.org/10.3390/diagnostics11081501

Ejemplares similares

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
por: Corma-Gómez, Anaïs, et al.
Publicado: (2022)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
por: Real, Luis Miguel, et al.
Publicado: (2019)

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians
por: Real, Luis M., et al.
Publicado: (2014)

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Liver Stiffness Using Transient Elastography is Applicable to Canines for Hepatic Disease Models
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life
por: Real, Luis M., et al.
Publicado: (2018)

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
por: Macías, Juan, et al.
Publicado: (2021)

Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR
por: Frías, Mario, et al.
Publicado: (2019)

CD46 Genetic Variability and HIV-1 Infection Susceptibility
por: Serrano-Rísquez, Carmen, et al.
Publicado: (2021)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
por: Rivero-Juárez, Antonio, et al.
Publicado: (2013)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

Limited Value of Single Sampling for IgM Antibody Determination as a Diagnostic Approach for Acute Hepatitis E Virus Infection
por: Rivero-Juarez, Antonio, et al.
Publicado: (2021)

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
por: Neukam, Karin, et al.
Publicado: (2015)

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort
por: Neukam, Karin, et al.
Publicado: (2016)

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study
por: López-Cortés, Luis F, et al.
Publicado: (2010)

Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release
por: Corma, Avelino, et al.
Publicado: (2022)

Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis
por: Miravitlles, Marc, et al.
Publicado: (2022)

Role of Hepatitis E Virus Infection in Acute-on-Chronic Liver Failure
por: Frias, Mario, et al.
Publicado: (2018)

Hepatitis E Infection in HIV-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2019)

Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients
por: Corchado, Sara, et al.
Publicado: (2014)

Mutations in the Progesterone Receptor (PROGINS) May Reduce the Symptoms of Acute Hepatitis E and Protect Against Infection
por: López-López, Pedro, et al.
Publicado: (2019)

Thin-Wall Machining of Light Alloys: A Review of Models and Industrial Approaches
por: Del Sol, Irene, et al.
Publicado: (2019)

Human Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis
por: Lopez-Lopez, Pedro, et al.
Publicado: (2019)

Historical and ecological drivers of the spatial pattern of Chondrichthyes species richness in the Mediterranean Sea
por: Meléndez, María José, et al.
Publicado: (2017)

Multilayer homogeneous dielectric filler for electromagnetic invisibility
por: Serna, Alberto, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uci7ckr6lm1ktiqm1kk75notmb